New AD drug

Kurt A. Kistler kistler at a.chem.upenn.edu
Thu Jun 16 21:45:34 EST 1994


Dag Stenberg (stenberg at cc.Helsinki.FI) wrote:
: Kurt A. Kistler (kistler at a.chem.upenn.edu) wrote:
: > Does anyone know anything about the new AD drug that is going through clinical
: > trials right now?  It's called something like Salbelusol, and the short radio
: > report on it stated it was not a AChE inhibitor.  

: Salb... suggests something different, but I would have suspected that a
: new drug in clinical trials would be tacrine.
:   Tacrine just got prohibited in Sweden, and no more clinical trials 
: will be allowed. This might interest some people...

I believe Tacrine is on the  U.S. market now, even though it does not
do such a great job.  Are AChE inhibitors a waste of time?

--
Kurt


       ||                      |
    \\ || //                   |   Kurt A. Kistler
     \\||//                    |   University of Pennsylvania
     //||\\  The way of water. |   Department of Chemistry
    // || \\                   |   kistler at a.chem.upenn.edu
   // \||  \\                  |



More information about the Neur-sci mailing list